Gå til hovedinnhold

Jennifer Gjerde

C%3A%5CUsers%5Ca21291%5CPictures%5CIMG 8709 %28002%29
Senioringeniør
Telefon: 93652137
Avdeling: Næringsstoff laboratorium

Fish and animal feed.

Arbeidsområde

Expertise and experience: 

- Feed

- Fish

- Pharmacogenetics and pharmacokinetic studies in cells, animal and human. 

- Implement analytical methods that involve experimental design and problem solving cases.

- Uses LC-MS and LC-MS/MS for quantitative analysis of analytes in biological matrices and animal feed. 

- Vitamin, synthetic antioxidants and proteomics.

- Anticancer drug and breast cancer.

Publikasjoner

Vitenskapelige artikler (NVI)

The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. Int J Obes (Lond).

2012

Veum VL, Dankel SN, Gjerde J, Nielsen HJ, Solsvik MH, Haugen C, et al.
36(9)
2020

Validation and Determination of 25(OH) Vitamin D and 3-Epi25(OH)D3 in Breastmilk and Maternal- and Infant Plasma during Breastfeeding

Jennifer Gjerde, Marian Kjellevold, Lisbeth Dahl, Torill Berg, Annbjørg Bøkevoll, Maria Wik Markhus
Nutrients 12
2020

Validation and Determination of 25(OH) Vitamin D and 3-Epi25(OH)D3 in Breastmilk and Maternaland Infant Plasma during Breastfeeding

Jennifer Gjerde, Marian Kjellevold, Lisbeth Dahl, Torill Berg, Annbjørg Bøkevoll and MariaWik Markhus
Nutrients 12 p. 2271
2019

Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer

Harriet Johansson, Valentina Aristarco, Sara Gandini, Jennifer Gjerde, Debora Macis, Aliana Guerrieri-Gonzaga, Davide Serrano, Matteo Lazzeroni, Agnita Rajasekaran, Clark V. Williard, Gunnar Mellgren, Andrea DeCensi, Bernardo Bonanni
The Pharmacogenomics Journal p. 1-8
2019

Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database

Thomas Helland, Kari Britt Hagen, Martha Eimstad Haugstøyl, Jan Terje Kvaløy, Siri Lunde, Kirsten Lode, Ragna Anne Lind, Birgitta Haga Gripsrud, Kristin Jonsdottir, Jennifer Gjerde, Ersilia Bifulco, Simon Steinar Hustad, Janne Jonassen, Turid Aas, Tone Hoel Lende, Ernst Asbjørn Lien, Emiel Janssen, Håvard Søiland, Gunnar Mellgren
Breast Cancer Research and Treatment 177 p. 185-195
2019

Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database

Thomas Helland, Kari Britt Hagen, Martha Eimstad Haugstøyl, Jan Terje Kvaløy, Siri Lunde, Kirsten Lode, Ragna Anne Lind, Birgitta Haga Gripsrud, Kristin Jonsdottir, Jennifer Gjerde, Ersilia Bifulco, Simon Steinar Hustad, Janne Jonassen, Turid Aas, Tone Hoel Lende, Ernst Asbjørn Lien, Emiel Janssen, Håvard Søiland, Gunnar Mellgren
Breast Cancer Research and Treatment 177
2019

Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer

Harriet Johansson, Valentina Aristarco, Sara Gandini, Jennifer Gjerde, Debora Macis, Aliana Guerrieri-Gonzaga, Davide Serrano, Matteo Lazzeroni, Agnita Rajasekaran, Clark V. Williard, Gunnar Mellgren, Andrea DeCensi, Bernardo Bonanni
The Pharmacogenomics Journal 2019
2018

Effect of Whey and Herring Roe Protein administered as a supplement to young healthy adults – A pilot study. I: Blue Growth: Aquaculture, Fisheries, Market and Health Perspectives..

Grete Hansen Aas, Elin Strand, Jennifer Gjerde, Anne Synnøve Røsvik, Per Christian Sæbø, Bodil Bjørndal
Orkana Forlag 2018
2018

A prospective, longitudinal, breast cancer biobank (PBCB) in western Norway.

Siri Lunde, Thomas Helland, Janne Jonassen, Haugstøyl Martha, Marie Austdal, Kirsten Lode, Kari-Britt Hagen, Birgitta Haga Gripsrud, Ragna Anne Lind, Jennifer Gjerde, Tone Hoel Lende, Bjørnar Gilje, Turid Aas, Kristin Jonsdottir, Ann Cathrine Kroksveen, Bjørg Erdal, Sissel Vevle, Jørn-Vegard Sagen, Satu Oltedal, Oddmund Nordgård, Kjersti Tjensvoll, Timothy Lash, Jan Terje Kvaløy, Emiel Janssen, Gunnar Mellgren, Håvard Søiland, Ernst Asbjørn. Lien
Europe Biobank Week (EBW)
2016

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen

Harriet Johansson, Sara Gandini, Davide Serrano, Jennifer Gjerde, Monia Lattanzi, Debora Macis, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Gunnar Mellgren, Ernst Asbjørn Lien, Andrea Decensi, Bernardo Bonanni
Breast Cancer Research and Treatment 159 p. 97-108
2016

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen

Johansson H, Gandini S, Serrano D, et al
Breast Cancer Res Treat 159(1):97-108.
2015

The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells

Thomas Helland, Jennifer Gjerde, Simon N Dankel, Ingvild Sveinsgjerd Fenne, Linn Skartveit, Andreas Drangevåg, Olivera Bozickovic, Marianne Hauglid Flågeng, Håvard Søiland, Gunnar Mellgren, Ernst Asbjørn Lien
PLOS ONE 10
2015

Estrogens correlate with PELP1 expression in ER positive breast cancer

Marianne Hauglid Flågeng, Stian Knappskog, Jennifer Gjerde, Per Eystein Lønning, Gunnar Mellgren
PLOS ONE 10:e0134351
2015

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer

Flageng MH, Knappskog S, Gjerde J, Lonning PE, Mellgren G
PLoS One 10(8)
2015

The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells

Helland T, Gjerde J, Dankel S, et al.
PLoS One 10(4)
2014

Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults

Bodil Bjørndal, Elin Strand, Jennifer Gjerde, Pavol Bohov, Asbjørn M. Svardal, Bernd W.K. Diehl, Sheila M. Innis, Alvin Berger, Rolf Kristian Berge
Lipids in Health and Disease 13:82
2014

Illness uncertainty in breast cancer patients: Validation of the 5-item short form of the Mishel Uncertainty in Illness Scale

Kari Britt Hagen, Turid Aas, Kirsten Lode, Jennifer Gjerde, Ernst Asbjørn Lien, Jan Terje Kvaløy, Timothy L Lash, Håvard Søiland, Ragna Anne Lind
European Journal of Oncology Nursing p. 1-7
2014

Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults

Bjorndal B, Strand E, Gjerde J, et al.
Lipids Health Dis. May 17
2013

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

Ernst Asbjørn Lien, Håvard Søiland, Steinar Lundgren, Turid Aas, Vidar Martin Steen, Gunnar Mellgren, Jennifer Gjerde
Breast Cancer Research and Treatment 141 p. 243-248
2013

Changes in adipose glucocorticoid metabolism before and after bariatric surgery assessed by direct hormone measurements

Paal Methlie, Simon E Nitter Dankel, Tone Sæterdal Myhra, Bjørn Jostein Christensen, Jennifer Gjerde, Dag Jone Stokke Fadnes, Villy Våge, Kristian Løvås, Gunnar Mellgren
Obesity 21 p. 2495-2503
2013

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

Davide Serrano, Matteo Lazzeroni, Sara Gandini, Debora Macis, Harriet Johansson, Jennifer Gjerde, Ernst Asbjørn Lien, Irene Feroce, Giancarlo Pruneri, Maria T Sandri, Fabio Bassi, Fabricio Brenelli, Alberto Luini, Massimiliano Cazzaniga, Clara Varricchio, Aliana Guerrieri-Gonzaga, Andrea Decensi, Bernardo Bonanni
Breast Cancer Research 15
2013

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment.

Lien EA, Soiland H, Lundgren S, Aas T, Steen VM, Mellgren G, et al.
Breast Cancer Res Treat
2013

Changes in adipose glucocorticoid metabolism before and after bariatric surgery assessed by direct hormone measurements

Methlie P, Dankel S, Myhra T, Christensen BR, Gjerde J, Fadnes D, et al.
Obesity (Silver Spring)
2013

A randomized phase II pre-surgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor positive breast cancer

Serrano D, Lazzeroni M, Gandini S, Macis D, Johansson H, Gjerde J, et al.
Breast Cancer Res 15(3)
2013

Breaking away: high fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients

Soiland H, Hagen KB, Gjerde J, Lende TH, Lien EA.
Acta Oncol. 52(4) p. 861-862
2012

The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss

Vivian Lohmann Veum, Simon E Nitter Dankel, Jennifer Gjerde, Hans Jørgen Nielsen, Margit Hildershavn Solsvik, Christine Haugen, Bjørn Jostein Christensen, Tuyen Hoang, Dag Jone Stokke Fadnes, Christian Busch, Villy Våge, Jørn V. Sagen, Gunnar Mellgren
International Journal of Obesity 36 p. 1195-1202
2012

Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer

Line Leonore Haugan Moi, Marianne Hauglid Flågeng, Jennifer Gjerde, Andre Greger Madsen, Therese Halvorsen Røst, Oddrun Anita Gudbrandsen, Ernst Asbjørn Lien, Gunnar Mellgren
BMC Cancer 12
2012

Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide

Jennifer Gjerde, Sara Gandini, Aliana Guerrieri-Gonzaga, Line Leonore Haugan Moi, Valentina Aristarco, Gunnar Mellgren, Andrea Decensi, Ernst Asbjørn Lien
Breast Cancer Research and Treatment 134 p. 693-700
2012

Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.

Moi LL, Flageng MH, Gjerde J, Madsen A, Rost TH, Gudbrandsen OA, et al.
BMC Cancer 12:247
2011

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

Davide Serrano, Matteo Lazzeroni, Carlo–Federico Zambon, Debora Macis, Patrick Maisonneuve, Harriet Ann Johansson, Aliana Guerrieri-Gonzaga, Mario Plebani, Daniela Basso, Jennifer Gjerde, Gunnar Mellgren, Nicole Rotmensz, Andrea Decensi, Bernardo Bonanni
The Pharmacogenomics Journal 11 p. 100-107
2011

Functional polymorphisms in UDP-glucuronosyltransferases and recurrence in tamoxifen-treated breast cancer survivors

Thomas P. Ahern, Mariann Christensen, Deirdre P. Cronin-Fenton, Kathryn L. Lunetta, Håvard Søiland, Jennifer Gjerde, Jens Peter Garne, Carol L. Rosenberg, Rebecca A. Silliman, Henrik Toft Sørensen, Timothy L. Lash, Stephen Hamilton-Dutoit
Cancer Epidemiology, Biomarkers and Prevention 20 p. 1937-1943
2011

Sulfotransferase 1A1 and estrogen receptor influence the 17β-estradiol level in tumor tissues of postmenopausal women

Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Soiland H, Gjerde J, et al. Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.
Cancer Epidemiol Biomarkers Prev. 20(9)
2011

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial.

Serrano D, Lazzeroni M, Zambon CF, Macis D, Maisonneuve P, Johansson H, et al.
Pharmacogenomics J. 11(2) p. 100-7
2011

The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.

Veum VL, Dankel SN, Gjerde J, Nielsen HJ, Solsvik MH, Haugen C, et al.
Int J Obes (Lond)
2010

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

Jennifer Gjerde, Jürgen Geisler, Steinar Lundgren, Dagfinn Ekse, Jan Erik Varhaug, Gunnar Mellgren, Vidar Martin Steen, Ernst Asbjørn Lien
BMC Cancer 10
2010

Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue

Line Leonore Haugan Moi, Marianne Hauglid Flågeng, Sara Gandini, Aliana Guerrieri-Gonzaga, Bernardo Bonanni, Matteo Lazzeroni, Jennifer Gjerde, Ernst Asbjørn Lien, Andrea De Censi, Gunnar Mellgren
Clinical Cancer Research 16 p. 2176-2186
2010

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer.

Gjerde J, Geisler J, Lundgren S, Ekse D, Varhaug JE, Mellgren G, et al.
BMC Cancer
2010

Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.

Haugan Moi LL, Hauglid Flageng M, Gandini S, Guerrieri-Gonzaga A, Bonanni B, Lazzeroni M, et al.
Clin Cancer Res. 2010 16(7) p. 2176-86.
2010

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial.

Serrano D, Lazzeroni M, Zambon CF, Macis D, Maisonneuve P, Johansson H, et al.
Pharmacogenomics J.
2008

Tamoxifen impairs both longitudinal and cortical bone growth in young male rats

Elham Karimian, Andrei S Chagin, Jennifer Fernandez Gjerde, Terhi Heino, Ernst Asbjørn Lien, Claes Ohlsson, Lars Sävendahl
Journal of Bone and Mineral Research 23 p. 1267-1277
2008

Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism

Jennifer Fernandez Gjerde, Marianne Hauglid, M Hauglid, Harald Breilid, S. Lundgren, Jan Erik Varhaug, Elton Richard Kisanga, Gunnar Mellgren, Vidar Martin Steen, Ernst Asbjørn Lien
Annals of Oncology 19 p. 56-61
2008

Tamoxifen Impairs Both Longitudinal and Cortical Bone Growth in Young Male Rats.

Karimian E, Chagin AS, Gjerde J, Heino T, Lien EA, Ohlsson C, et al.
J Bone Miner Res.
2007

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users

Andrea Decensi, Sara Gandini, Davide Serrano, Massimiliano Cazzaniga, Maria Pizzamiglio, Fausto Maffini, Giuseppe Pelosi, Christina Daldoss, Umberto Omodei, Harriet Johansson, Debora Macis, Matteo Lazzeroni, Mauro Penotti, Laura Sironi, Simona Moroni, Vanda Bianco, Gabriella Rondanina, Jennifer Fernandez Gjerde, Aliana Guerrieri-Gonzaga, Bernardo Bonanni
Journal of Clinical Oncology 25 p. 4201-4209
2007

A study of association between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferae 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady sate tamoxifen treatment

Jennifer Gjerde, Jurgen Geisler, Steinar Lundgren, Dagfinn Ekse, H Breilid, M Hauglid, Jan Erik Varhaug, G Mellgren, VM Steen, Per Eystein Lønning, Ernst A Lien
Breast Cancer Research and Treatment 106 p. S144-S144
2007

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users.

Decensi A, Gandini S, Serrano D, Cazzaniga M, Pizzamiglio M, Maffini F, et al.
J Clin Oncol. 25(27)
2007

A study of associations between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferase 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady state tamoxifen treatment.

Gjerde J, Geisler J, Lundgren S, Ekse D, Breilid H, Hauglid M, et al.
Breast Cancer Res Treat. 106
2007

Effect of CYP2D6 and SULT1A1 Genotypes on the serum concentration of 4-OHtamoxifen and 4-OH-N-Demethyltamoxifen during steady state treatment of breast cancer patients.

Gjerde J, Hauglid M, Breilid H, Lundgren S, Kisanga ER, Mellgren G, et al.
Breast 16
2006

Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats

Jan Schjøtt, Jennifer Gjerde, Elton Richard Kisanga, Ernst Asbjørn Lien
98 p. 231-234
2006

Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats.

Schjott J, Gjerde J, Kisanga ER, Lien EA.
Basic Clin Pharmacol Toxicol. 98(2). p. 231-4
2005

Induction of hepatic drug-metabolising enzymes and tamoxifen metabolite profile in relation to administration route during low-dose treatment in nude rats

Elton Richard Kisanga, Line Leonore Haugan Moi, Jennifer Gjerde, Gunnar Mellgren, Ernst Asbjørn Lien
Journal of Steroid Biochemistry and Molecular Biology 94 p. 489-498
2005

Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry

Jennifer Fernandez Gjerde, Elton Richard Kisanga, Marianne Hauglid, Pål Ivar Holm, Gunnar Mellgren, Ernst Asbjørn Lien
Journal of Chromatography A 1082 p. 6-14
2005

Relationship between CYP2D6 and SULT1A1 genotypes and serum concentrations of tamoxifen and its metabolites during steady state treatment in breast cancer patients.

Gjerde J, Hauglid M, Breilid H, Lundgren S, Kisanga ER, Mellgren G, et al.
Breast Cancer Res Treat. 94
2005

Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.

Gjerde J, Kisanga ER, Hauglid M, Holm PI, Mellgren G, Lien EA.
J Chromatogr A. 1082(1) p. 6-14.
2005

Induction of hepatic drug-metabolising enzymes and tamoxifen metabolite profile in relation to administration route during low-dose treatment in nude rats.

Kisanga ER, Moi LL, Gjerde J, Mellgren G, Lien EA.
J Steroid Biochem Mol Biol. 94(5) p. 489-98.
2004

Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in randomized preoperative trial

Elton Richard Kisanga, Jennifer Gjerde, Aliana Guerrieri-gonzaga, Francesca Pigatto, Adriana Pesci - feltri, Chris Robertson, Davide Serrano, Giuseppe Pelosi, Andrea Decensi, Ernst Asbjørn Lien
Clinical Cancer Research 10 p. 2336-2343
2004

Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial.

Kisanga ER, Gjerde J, Guerrieri-Gonzaga A, Pigatto F, Pesci-Feltri A, Robertson C, et al.
Clin Cancer Res. 10(7) p. 2336-43.
2003

Tamoxifen administration and metabolism in nude mice and nude rats

Elton Richard Kisanga, Jennifer Gjerde, Jan Schjøtt, Gunnar Mellgren, Ernst Asbjørn Lien
Journal of Steroid Biochemistry and Molecular Biology 84 p. 361-367
2003

Tamoxifen administration and metabolism in nude mice and nude rats.

Kisanga ER, Gjerde J, Schjott J, Mellgren G, Lien EA.
J Steroid Biochem Mol Biol. 84(2-3) p. 361-7.

Poster

2018

A prospective, longitudinal, breast cancer biobank (PBCB) in western Norway

Siri Lunde, Thomas Helland, Janne Jonassen, Haugstøyl Martha, Marie Austdal, Kirsten Lode, Kari-Britt Hagen, Birgitta Haga Gripsrud, Ragna Anne Lind, Jennifer Gjerde, Tone Hoel Lende, Bjørnar Gilje, Turid Aas, Kristin Jonsdottir, Ann Cathrine Kroksveen, Bjørg Erdal, Sissel Vevle, Jørn-Vegard Sagen, Satu Oltedal, Oddmund Nordgård, Kjersti Tjensvoll, Timothy Lash, Jan Terje Kvaløy, Emiel Janssen, Gunnar Mellgren, Håvard Søiland, Ernst Asbjørn Lien
2011

The nuclear receptors NURR77, NURR1 and NOR1 in obesity and during fat loss

Vivian Lohmann Veum, Simon E Nitter Dankel, Jennifer Gjerde, Hans Jørgen Nielsen, Margit Hildershavn Solsvik, Christine Haugen, Bjørn Jostein Christensen, Tuyen Hoang, Christian Busch, Dag Jone Stokke Fadnes, Villy Våge, Jørn V. Sagen, Gunnar Mellgren
2010

The influence of tamoxifen treatment on the expression levels of liver receptor homolog (LHR-1)

Jennifer Gjerde, Aliana Guerrieri-gonzaga, Marianne Hauglid Flågeng, Sara Gandini, Line Haugan Moi, Bernardo Bonanni, Debora Macis, Harriet Johansson, Andrea Decensi, Gunnar Mellgren, Ernst A. Lien
2010

Effects of CYP2C19 genotype on tamoxifen and estrogen metabolism

Jennifer Gjerde, Jurgen Geisler, Steinar Lundgren, D. Ekse, Jan Erik Varhaug, Gunnar Mellgren, Vidar Martin Steen, Ernst A. Lien
2010

Distribution of tamoxifen and five metabolites into normal and malignant human breast cancer tissue during conventional and low dose treatment

Jennifer Gjerde, Aliana Guerrieri-Gonzaga, Bernardo Bonanni, Sara Gandini, Debora Macis, Gunnar Mellgren, Andrea De Censi, Ernst A Lien
2010

Expression of Steroid Receptor Coactivators and HER-2/neu in normal and malignant breast tissue in controls and tamoxifen treated patients

Marianne Hauglid Flågeng, Line Leonore Haugan Moi, Sara Gandini, Aliana Guerrieri Gonzaga, Bernardo Bonanni, Matteo Lazzeroni, Jennifer Gjerde, Ernst Asbjørn Lien, Andrea Decensi, Gunnar Mellgren
2009

Relations between FSH, SHBG and tamoxifen metabolism during steady state tamoxifen treatment

Jennifer Gjerde, Jürgen Geisler, Steinar Lundgren, Dagfinn Ekse, Jan Erik Varhaug, Gunnar Mellgren, Per Eystein Lønning, Ernst Asbjørn Lien
2007

A study of association between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferae 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady sate tamoxifen treatment

Jennifer Gjerde, Jurgen Geisler, Steinar Lundgren, Dagfinn Ekse, H Breilid, M Hauglid, Jan Erik Varhaug, G Mellgren, VM Steen, Per Eystein Lønning, Ernst A Lien
2007

Effect of CYP2D6 and SULT1A1 Genotypes on the serum concentration of 4-OHtamoxifen and 4-OH-N-Demethyltamoxifen during steady state treatment of breast cancer patients

Jennifer Fernandez Gjerde, Marianne Hauglid, Harald Breilid, Steinar Lundgren, Elton Richard Kisanga, Gunnar Mellgren, Vidar Martin Steen, Ernst Asbjørn Lien
2005

Relationship between CYP2D6 and SULT1A1 genotype and serum concentration of tamoxifen and its metabolites during steady state treatment in breast cancer patients

Jennifer Gjerde, M Hauglid, H Breilid, Steinar Lundgren, JE Varhaug, ER Kisanga, G Mellgren, VM Steen, Ernst A Lien
2005

Relationship between CYP2D6 and SULT1A1 genotypes and serum concentrations of tamoxifen and its metabolites during steady state treatment in breast cancer patients

Jennifer Fernandez Gjerde, Marianne Hauglid, Harald Breilid, Steinar Lundgren, Jan Erik Varhaug, Elton Richard Kisanga, Gunnar Mellgren, Vidar Martin Steen, Ernst Asbjørn Lien
2005

Effects of low-dose tamoxifen treatment on expression of drug-metabolising enzymes in rat liver in relation to administration route

Line Leonore Haugan Moi, Elton Richard Kisanga, Jennifer Gjerde, Gunnar Mellgren, Ernst Asbjørn Lien
2004

Quantification of serum tamoxifen and metabolites by liquid chromatography-tandem mass spectrometry

Jennifer Gjerde, Ernst Asbjørn Lien
2004

Tamoxifen metabolism and induction of hepatic drug-metabolizing enzymes in nude rats

Line Leonore Haugan Moi, Elton Richard Kisanga, Jennifer Gjerde, Gunnar Mellgren, Ernst Asbjørn Lien
2002

Tamoxifen metabolism in immunocompromised rats and mice

Elton Richard Kisanga, Jennifer Fernandez Gjerde, Gunnar Mellgren, Ernst Asbjørn Lien

Kapitler og bøker

2018

Effect of Whey and Herring Roe Protein administered as a supplement to young healthy adults – A pilot study

Grete Hansen Aas, Elin Strand, Jennifer Gjerde, Anne Synnøve Røsvik, Per Christian Sæbø, Bodil Bjørndal
2012

Tamoxifen metabolism and biological activity

Jennifer Gjerde, Line Leonore Haugan Moi, Gunnar Mellgren, Ernst Asbjørn Lien
p. 7-28
2012

Tamoxifen metabolism and biological activity. Tamoxifen: Properties, Biological Activity and Health Benefits.

Gjerde J, Moi LL, Mellgren G, Lien EA.
Nova Publishers Inc, New York, USA. .
2011

Steroid Receptor Coactivators and Their Expression, Regulation and Functional Role in Endocrine Responsive and Resistant Breast Cancer

Line Leonore Haugan Moi, Marianne Hauglid Flågeng, Ingvild Sveinsgjerd Fenne, Jennifer Gjerde, Ernst Asbjørn Lien, Gunnar Mellgren
p. 715-732
2011

Steroid Receptor Coactivators and Endocrine Treatment in Breast Cancer

Line Leonore Haugan Moi, Marianne Hauglid Flågeng, Simon E Nitter Dankel, Tuyen Hoang, Jennifer Gjerde, Jørn V. Sagen, Ernst Asbjørn Lien, Gunnar Mellgren
p. 35-66
2011

Steroid Receptor Coactivators and Endocrine Treatment in Breast Cancer. I: Nuclear Receptors. Nuclear Receptors.

Haugan Moi LL, Hauglid Flågeng M, Dankel S, N., Hoang H, Gjerde J, Sagen JV, et al.
Nova Science Publishers, Inc
2011

Steroid Receptor Coactivators and Their Expression, Regulation and Functional Role in Endocrine Responsive and Resistant Breast Cancer. I: Breast Cancer - Carcinogenesis, Cell Growth and Signalling Pathways.

Haugan Moi LL, Hauglid Flågeng M, Dankel S, N., Hoang H, Gjerde J, Sagen JV, et al.
INTECH

Faglige foredrag

2010

Estrogen Receptor degradation

Gjerde, Jennifer
2005

Distribution of tamoxifen in serum and breast cancer tissue and its effects on sex hormone-binding globulin (SHBG)

Jennifer Fernandez Gjerde, Ernst Asbjørn Lien

Annet tidsskriftbidrag

2013

Breaking away: High fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients

Håvard Søiland, Kari Britt Hagen, Jennifer Gjerde, Tone Hoel Lende, Ernst Asbjørn Lien
Acta Oncologica 52 p. 861-U216
2013

Associations between tamoxifen and age during steady state tamoxifen treatment of postmenopausal women with breast cancer

Ernst Asbjørn Lien, Håvard Søiland, Jennifer Gjerde
121
2010

Effects of CYP2C19 genotype on tamoxifen and estrogen metabolism

Jennifer Gjerde, Jürgen Geisler, Steinar Lundgren, Dagfinn Ekse, Jan Erik Varhaug, Gunnar Mellgren, Vidar Martin Steen, Ernst Asbjørn Lien
European Journal of Cancer 8 p. 60-60
2008

A study of associations between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferase 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady state tamoxifen treatment

Jennifer Fernandez Gjerde, Jurgen Geisler, Steinar Lundgren, Dagfinn Ekse, Harald Breilid, Marianne Hauglid, M Hauglid, EJ Varhaug, Jan Erik Varhaug, Vidar Martin Steen, Per Eystein Lønning, PE Lonning, Ernst Asbjørn Lien
Breast Cancer Research and Treatment 109 p. 592-592
2007

Effect of CYP2D6 and SULT1A1 genotypes on the serum concentration of 4-hydroxytamoxifen and 4-hydroxy-N-demethyltamoxifen during steady state treatment of breast cancer patients

Jennifer Fernandez Gjerde, Marianne Hauglid, Harald Breilid, Steinar Lundgren, Jan Erik Varhaug, Elton Richard Kisanga, Gunnar Mellgren, Vidar Martin Steen, Ernst Asbjørn Lien
Breast 16 p. S15-S15
2007

A study of associations between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferase 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady state tamoxifen treatment

Jennifer Fernandez Gjerde, Jurgen Geisler, Steinar Lundgren, Dagfinn Ekse, Harald Breilid, Marianne Hauglid, Jan Erik Varhaug, Gunnar Mellgren, Vidar Martin Steen, Per Eystein Lønning, Ernst Asbjørn Lien
Breast Cancer Research and Treatment S106
2005

Relationship between CYP2D6 and SULT1A1 genotypes and serum concentrations of tamoxifen and its metabolites during steady state treatment in breast cancer patients

Jennifer Fernandez Gjerde, Marianne Hauglid, Harald Breilid, Steinar Lundgren, Jan Erik Varhaug, Elton Richard Kisanga, Gunnar Mellgren, Vidar Martin Steen, Ernst Asbjørn Lien
Breast Cancer Research and Treatment 94 p. S236-S237

Rapporter og avhandlinger

2010

CYP2C19 single nucleotide polymorphisms And their effects on the metabolism of Tamoxifen in breast cancer patients

Jennifer Gjerde, Ernst A Lien, Johannes Aursland
2008

Tamoxifen treatment of breast cancer: Pharmacogenetics and therapeutic drug monitoring

Gjerde, Jennifer
Er denne profilen din? Rediger denne profilen (logg inn)